Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Indian Tribunal Back Zenotech, Daiichi Sankyo's Struggle On Open Offer Price Continues

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Daiichi Sankyo's year-long struggle to wrest control of India's biotech and oncology start-up Zenotech Labs received yet another setback as the Securities Appellate Tribunal backed the founder promoters of the Hyderabad-based company led by Jayaram Chigurupati and asked the Japanese company to increase the offer price for the shares to further bolster its shareholding
Advertisement

Related Content

In Its Second Biotech Deal In Three Months, Ranbaxy Signs Pact With Pfenex For An Undisclosed Biosimilar
In Its Second Biotech Deal In Three Months, Ranbaxy Signs Pact With Pfenex For An Undisclosed Biosimilar
Ranbaxy Buys Biovel For An Entry Into Vaccines and Biotherapeutics
Ranbaxy Buys Biovel For An Entry Into Vaccines and Biotherapeutics
Ranbaxy Buys Biovel For An Entry Into Vaccines and Biotherapeutics
Ranbaxy Buys Biovel For An Entry Into Vaccines and Biotherapeutics
Daiichi Sankyo, Ranbaxy To Start Joint Marketing In Mexico, Romania
Daiichi Sankyo, Ranbaxy To Start Joint Marketing In Mexico, Romania
India's Zenotech Ups Noise Against Daiichi Sankyo; Demands $20 Million In Damages
India's Zenotech Ups Noise Against Daiichi Sankyo; Demands $20 Million In Damages
Advertisement
UsernamePublicRestriction

Register

SC070235

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel